Sen. Susan Collins publicly rebukes proposed 10% NIH funding cut

Sen. Susan Collins used a May 21 Senate hearing to break publicly with the Trump administration’s proposal to cut National Institutes of Health funding by about 10%, calling the request “inexplicable.” The Maine Republican, who chairs the Senate Appropriations Committee, delivered the criticism directly to NIH Director Jay Bhattacharya during a hearing on the administration’s fiscal 2027 budget request. Her remarks put a senior Republican appropriator on record against one of the White House’s highest-profile proposed reductions in biomedical research spending. ### Where did Collins make the break with the White House? The Senate Appropriations Committee held the hearing on May 21 as part of its review of the NIH budget request for fiscal 2027. Collins said the administration’s proposed reductions to biomedical research funding, along with a proposed one-size-fits-all cap on indirect research costs, were “inexplicable,” according to Politico and the committee’s own release. (politico.com) Washington’s budget fight is now moving through the annual appropriations process, where committee chairs can shape spending bills long before they reach the Senate floor. Collins’s position matters because she is not an outside critic; she controls the panel that writes the chamber’s spending legislation. ### How large is the proposed NIH cut? President Donald Trump’s request would reduce the NIH budget by roughly $5 billion next year, Politico reported, which Collins described as about a 10% cut. (politico.com) The same proposal also includes limits on indirect cost reimbursements, a long-running flashpoint between the administration and research institutions that rely on those funds to support facilities, compliance and administrative overhead. (appropriations.senate.gov) The committee release said Collins linked her objections to recent advances in areas including clinical trials and diabetes research, arguing that those gains depended on sustained federal support. Her comments placed biomedical research alongside other programs that appropriators in both parties have historically defended during budget negotiations. (politico.com) ### Why are researchers watching this fight so closely now? NPR reported on May 21 that scientists say federal grants have in many cases been restored on paper but that the administration is still preventing money from reaching labs on schedule. Researchers told NPR the delays were already affecting staffing, project continuity and morale, with one Harvard scientist describing the disruption as a “10-year hit to a lab.” (appropriations.senate.gov) Johns Hopkins President Ron Daniels and University of Kansas Chancellor Douglas Girod made a related argument in a Wall Street Journal op-ed highlighted by Johns Hopkins on May 21. They urged federal agencies to release congressionally appropriated research funds, saying the U.S. research enterprise was being constrained not only by proposed cuts but also by delayed disbursement. (wbur.org) ### Is Collins the only lawmaker raising objections? Patty Murray, the committee’s Democratic vice chair, also pressed Bhattacharya at the same hearing over the administration’s proposed medical research cuts, according to the Appropriations Committee site. Collins’s intervention stood out because it came from the Republican chair overseeing the panel. Congress has already shown resistance to NIH reductions in earlier funding fights. (hub.jhu.edu) A February analysis by McDermott+Consulting said lawmakers rejected proposed NIH cuts in the fiscal 2026 appropriations package and instead increased the agency’s budget, underscoring the agency’s bipartisan support on Capitol Hill. ### What comes next in the NIH budget fight? Fiscal 2027 appropriations hearings are now underway, and the Senate committee’s NIH review on May 21 was one of the first formal steps in that process. (appropriations.senate.gov) Collins, Murray and Bhattacharya are likely to remain central figures as the Senate drafts its spending bill and negotiates with the House and the White House in the months ahead. The immediate milestones are the subcommittee and full-committee appropriations stages, where lawmakers decide whether to follow, revise or reject the administration’s request. (jm-aq.com) For universities and medical centers, the outcome will determine not only the topline NIH budget for fiscal 2027 but also whether indirect cost rules and grant-flow disputes remain part of the final package. (appropriations.senate.gov)